News: Brokerage

New York remains a top market for life sciences research talent according to CBRE analysis

Manhattan, NY The Greater New York market ranked fourth in the nation for life sciences research talent, according to a recent analysis conducted by CBRE. Nationally, the growth of U.S. life sciences researchers remains resilient in the face of economic concerns, with the number of life sciences researchers in the U.S. increasing by 87% over the past 20 years, compared with 14% for all U.S. occupations. Research jobs have not fallen across those 20 years, through three recessions and amid the tight labor market of recent years.

“New York’s high placement is thanks to a dense concentration of talent in the region’s core in the vicinity of Manhattan, Brooklyn, and Queens with additional concentrations of talent in Central New Jersey, Northern New Jersey, Westchester County, and Long Island,” said Bill Hartman, vice chairman of CBRE based in the Midtown New York office.

New York’s robust performance is supported by a workforce of 38,700 life sciences research professionals – the largest in the country – and 9,500 annual relevant degree completions at area universities – also the largest in the country.

“New York’s strong position as a top market for life sciences research talent is bolstered by some of the region’s top universities and colleges, including New York University, Columbia University, Weill Cornell, Rockefeller University, Memorial Sloan Kettering and Stony Brook University,” said Joseph DeRosa, CBRE senior vice president.

New York is situated at the center of a cluster of life sciences powerhouses that spans 450 miles along the northeast corridor and includes other top-ranked markets including Boston (1), Washington, D.C./Baltimore (3), and Philadelphia (6) and includes promising smaller markets such as Worcester (17), Albany (21), and New Haven (24). Altogether, northeastern markets account for four of the top ten and seven of the top 25 markets. Among the ten leading markets, the Northeast accounts for 57% of life sciences talent and 56% of annual graduates.

According to CBRE’s report, New York boasts some of the highest wages in the life sciences market ranging from $128,274 for biochemists to $98,669 for chemists. The yearly cost of living in the area as of 2021 was $69,246 and the median home value stood at $517,738, while the average apartment rent for a one bedroom was $2,857.

Life sciences research professions – from biochemists to epidemiologists and data scientists – increased in headcount by 3.1% in 2022 to a record 545,000 specialists. In comparison, the overall U.S. job growth rate last year was 2.2%. The continued growth in life sciences research jobs is driven by established markets such as Boston/Cambridge and the San Francisco Bay area and emerging hubs, including Atlanta, Dallas/Fort Worth and Miami/Fort Lauderdale.

CBRE evaluated each of the largest 74 U.S. life sciences labor markets against multiple criteria, including the number and concentration of life sciences researchers, number of new graduates with life sciences degrees and specifically with doctorate degrees in life sciences, concentration of all doctorate degree holders, and concentration of jobs in the broader professional, scientific, and technical services professions. The analysis produced CBRE’s second annual ranking of the leading markets for U.S. life sciences talent.

READ ON THE GO
DIGITAL EDITIONS
Subscribe
Columns and Thought Leadership
The anticipated effect of Basel III and ISO 20022 implementation on commercial real estate - by Michael Zysman

The anticipated effect of Basel III and ISO 20022 implementation on commercial real estate - by Michael Zysman

July 1, 2025 is the deadline for US banks to begin to adopt Basel III banking standards and July 14, 2025 is the deadline for U.S. banks to adopt ISO 20022 messaging standards. Both will have a significant effect on the banking and commercial real estate (CRE) finance sectors.
Tri-state capital  migrates nationally amid  regulation pressure - by Reese Weaver

Tri-state capital migrates nationally amid regulation pressure - by Reese Weaver

New York tri-state multifamily investors are increasingly reallocating capital to less-regulated markets across the U.S. as rent control and legislative risk erode returns at home. With over 60% of New York City’s rental housing stock classified as rent-stabilized, the traditional value-add model — buying under-performing buildings,

The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

There was a time when an offering memorandum (OM) was pretty bare bones, some photos, a few bullet points on income, and a rent roll thrown in at the back. That used to get the job done. Not anymore. In 2025, buyers are sharper, faster, and more selective. They’re looking
A fresh start - by Shallini Mehra and Amit Doshi

A fresh start - by Shallini Mehra and Amit Doshi

For the past several years, the New York City multifamily housing market has been defined by disruption. The combined impact of the HSTPA rent laws and a sharply higher interest rate environment has fundamentally reduced